Skip to main content
. 2012 Mar;24(1):77–82. doi: 10.1007/s11670-012-0077-z

Table 2. Expressions of HLA class I in CRC patients, benign colorectal diseases patients and healthy controls.

Groups HLA class I mRNA HLA class I protein
Healthy controls 0.99±0.27 145.58±38.14
Benign diseases 0.76±0.19 102.05±35.98*
CRC 0.48±0.21*# 87.44±34.01**#

*P<0.05, **P<0.01, compared with health controls; #P<0.05, compared with benign diseases patients.